Medindia

X

Lupin Gets FDA Approval to Market Generic Birth Control Pills in US

by Kathy Jones on  December 20, 2012 at 8:53 PM General Health News   - G J E 4
Lupin Pharmaceuticals has finally received the approval from the US Food and Drug Administration to market its oral contraceptive pills in the United States.
 Lupin Gets FDA Approval to Market Generic Birth Control Pills in US
Lupin Gets FDA Approval to Market Generic Birth Control Pills in US
Advertisement

The pills are a generic version of Yasmin, manufactured by Bayer Healthcare, and allows Lupin to carve a slice of the oral contraceptive market which has been growing at a rate of nearly 10 percent every year in the United States.

Advertisement
Conservative estimates by analysts predict that Lupin will be able to gain a 10 percent market share for the pills, potentially earning them over $27 million in annual sales.

The Mumbai-based drug maker released a statement saying, "Lupin will be marketing its Drospirenone and Ethinyl Estradiol tablets USP in a wallet pack of 28 tablets consisting of 21 yellow active tablets, each containing 3 mg Drospirenone and 0.03 mg Ethinyl Estradiol, and 7 white inert tablets."


Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All